Currently, there are 302.46M common shares owned by the public and among those 298.35M shares have been available to trade.
Insiders at the company have transacted a total of 34 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 28 of these insider trades were purchases, accounting for 781,405 shares. Insider sales of the common stock occurred on 6 occasions, with total insider shares sold totaling 10,167 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the script later moved the day high at 35.93, down -4.56%. The company’s stock has a 5-day price change of -1.48% and 38.43% over the past three months. ALLY shares are trading 1.20% year to date (YTD), with the 12-month market performance up to 8.60% higher. It has a 12-month low price of $21.58 and touched a high of $38.03 over the same period. ALLY has an average intraday trading volume of 1.14 shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.73%, 3.22%, and 22.95% respectively.
Institutional ownership of Ally Financial Inc (NYSE: ALLY) shares accounts for 89.52% of the company’s 302.46M shares outstanding.
It has a market capitalization of $10.66B and a beta (3y monthly) value of 1.39. The stock’s trailing 12-month PE ratio is 11.83, while the earnings-per-share (ttm) stands at $2.99. The company has a debt-to-equity ratio at 1.52. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.87% over the week and 2.72% over the month.
Earnings per share for the fiscal year are expected to increase by 4.75%, and 71.67% over the next financial year. EPS should shrink at an annualized rate of -3.60% over the next five years, compared to 0.18% over the past 5-year period.
Looking at the support for the ALLY, a number of firms have released research notes about the stock. Morgan Stanley stated their Overweight rating for the stock in a research note on February 08, 2024, with the firm’s price target at $37-$47.
